[Interferon alpha in the treatment of chronic myeloid leukemia. Promises, realities, and perspectives]

Sangre (Barc). 1998 Apr;43(2):137-46.
[Article in Spanish]
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Algorithms
  • Biomarkers, Tumor / analysis
  • Bone Marrow Transplantation
  • Clinical Trials as Topic
  • Fusion Proteins, bcr-abl / analysis
  • Hematopoiesis / drug effects
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Immunologic Factors / pharmacology
  • Immunologic Factors / therapeutic use*
  • Interferon-alpha / pharmacology
  • Interferon-alpha / therapeutic use*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
  • Middle Aged
  • Neoplasm Recurrence, Local / therapy
  • Randomized Controlled Trials as Topic
  • Treatment Outcome

Substances

  • Biomarkers, Tumor
  • Immunologic Factors
  • Interferon-alpha
  • Fusion Proteins, bcr-abl